In the BioHarmony Drug Report Database

"Preview" Icon

Tasonermin

Beromun (tasonermin) is a protein pharmaceutical. Tasonermin was first approved as Beromun on 1999-04-12. It has been approved in Europe to treat sarcoma.

 

Trade Name

 

Beromun
 

Common Name

 

tasonermin
 

ChEMBL ID

 

CHEMBL2107891
 

Indication

 

sarcoma
 

Drug Class

 

Growth factors: tumor necrosis factors

Image (chem structure or protein)

Tasonermin structure rendering